Eli Lilly says Zepbound can ease obstructive sleep apnea
Apr 17, 2024
Studies revealed that the medication reduced sleep apnea severity by nearly two-thirds.
One in seven drug supply chain issue reports tied to drug shortages
Apr 10, 2024
Supply disruptions increased for drugs with and without reports at the start of the COVID-19 pandemic.
Surveillance colonoscopy rarely IDs cancer in older adults
Apr 04, 2024
The yields are higher among patients with a prior advanced adenoma but do not vary significantly with age.
ACC: Semaglutide beneficial in obesity-related heart failure, type 2 diabetes
Apr 09, 2024
Larger reductions were seen in heart failure-related symptoms and physical limitations for patients with HFpEF and type 2 diabetes.
Single invitation for PSA screening cuts prostate cancer deaths
Apr 08, 2024
A small but significant reduction was seen in prostate cancer deaths, but no reduction was seen in all-cause mortality.
CDC: Tuberculosis case counts, rates increasing since 2020
Apr 01, 2024
Among all age groups and both US-born and non-US-born individuals, there were increases observed in national case counts.
Smartphone-based measures can help ID frontotemporal lobar degeneration
Apr 01, 2024
Individuals with frontotemporal lobar degeneration were accurately differentiated from controls with smartphone tests.
Eli Lilly reports temporary shortage of Humalog and Insulin Lispro Injection
Mar 25, 2024
Products are expected to be out of stock at wholesalers and pharmacies through the beginning of April.
Fourth mRNA COVID-19 vaccine immunogenic, safe
Mar 24, 2022
Vaccine efficacy 30% for BNT162b2(Pfizer) and 11 percent for mRNA-1273 (Moderna) against any SARS-CoV-2 infection.
Allergy history may up risk for reactions to mRNA COVID-19 vaccine
Nov 04, 2021
The risk for allergic reactions within three days of vaccination is higher for those with history of high-risk allergy, but most completed the two-dose regimen. The mRNA vaccines approved for use against...
